Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 15, 2023

BUY
$0.14 - $0.31 $5,787 - $12,814
41,338 Added 150.39%
68,825 $12,000
Q3 2022

Nov 07, 2022

BUY
$0.46 - $1.29 $12,644 - $35,458
27,487 New
27,487 $12,000
Q2 2021

Sep 17, 2021

SELL
$22.26 - $28.43 $452,634 - $578,095
-20,334 Closed
0 $0
Q1 2021

May 19, 2021

BUY
$8.02 - $32.01 $163,078 - $650,891
20,334 New
20,334 $539,000
Q2 2020

Aug 07, 2020

SELL
$4.01 - $6.88 $44,871 - $76,987
-11,190 Closed
0 $0
Q4 2019

Feb 04, 2020

BUY
$7.23 - $14.12 $80,903 - $158,002
11,190 New
11,190 $106,000

Others Institutions Holding RUBY

About Rubius Therapeutics, Inc.


  • Ticker RUBY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,357,000
  • Description
  • Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...
More about RUBY
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.